France Digital Diabetes Management Market Insight
Published: 03 September 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The France digital diabetes management market will be witnessing growth at a CAGR of 12.79%, attributed to the increasing incidence of diabetes, increased usage of continuous glucose monitoring devices, increasing use of mobile health applications, and growth in the diabetic telemedicine solutions market.
France Digital Diabetes Management Market Insights Forecasts to 2035
- The France Digital Diabetes Management Market Size Was Estimated USD 277.3 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 12.79% from 2025 to 2035
- The France Digital Diabetes Management Market Size is Expected to rise around USD 923.9 Million by 2035
Notable Insights for the France Digital Diabetes Management Market
- The Product based Segmentation shows that Continuous Glucose Monitors are leading in the France Digital Diabetes Management Market in 2025 due to increasing demands for glucose monitoring, patient compliance, and enhanced results in diabetes management.
- The end-user based Segmentation indicates that Individuals Segment will be leading in the France Digital Diabetes Management Market in 2025 due to increased use of self-monitoring devices and Mobile based diabetes monitoring devices.
- The global revenue generated by Abbott Laboratories for the fiscal year 2025 is forecasted to be approximately $42 billion, thanks to increased interest in continuous glucose monitoring technologies and digital diabetes technology.
- As anticipated, increased use of artificial intelligence-enabled analytical tools, connected wearables, and telehealth-based diabetes management platforms will ensure further growth of the market based on digital diabetes technology.
Download the eBook (ToC)
Research Methodologies Used to Analyze the France Digital Diabetes Management Market
The France digital diabetes management market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with diabetes device manufacturers, software developers, healthcare providers, endocrinologists, telehealth service providers, and industry experts to analyze demand trends, technology adoption, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, healthcare databases, scientific papers, reimbursement policies, and industry organizations associated with diabetes care and digital health technologies. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, pricing trends, and investment activities.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Digital Diabetes Management Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Digital Diabetes Management Market
- Abbott Laboratories
- Medtronic plc
- Roche Diabetes Care
- Dexcom, Inc.
- Ascensia Diabetes Care
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Glooko, Inc.
- Sanofi S.A.
- Johnson & Johnson
Recent Developments:
- In January 2026, Libre Assist is a new innovation from Abbott which has been introduced in the FreeStyle Libre family, offering instant food suggestions and customized advice to aid diabetes management.
- In September 2025, At the conference EASD 2025, Dexcom showcased new digital diabetes solutions such as Dexcom Smart Basal, which is an insulin titration module embedded in the product to ease the process of starting basal insulin.
Market Segmentation:
France Digital Diabetes Management Market, By Product Type
- Continuous Glucose Monitors
- Smart Insulin Pens
- Diabetes Management Platforms
- Wearable Devices
- Blood Glucose Monitoring Systems
France Digital Diabetes Management Market, By Technology
- Glucose Monitoring Devices
- Insulin Delivery Devices
- Diabetes Management Software
- Mobile Applications
France Digital Diabetes Management Market, By Application
- Blood Glucose Monitoring
- Insulin Management
- Remote Patient Monitoring
- Clinical Decision Support
- Patient Engagement & Self-Management
Expert Views:
The expansion of digital diabetes management market in France will be propelled by the increase in the number of patients with diabetes, increased use of telemedicine and other related innovations, and increased need for personalization of disease management. This will be driven by the use of continuous glucose monitoring system, artificial intelligence analytics, mobile health applications, and telemedicine-related care platforms.
Author: Govind and Krishna By Decisions Advisors and Consulting